Forget Aurora Cannabis (TSX:ACB) and Consider This Pot Stock for Massive Gains

While Aurora Cannabis stock continues to burn investor wealth, this pot company is poised to beat market returns in 2020.

| More on:
Cannabis stocks have fallen.

We have seen how Aurora Cannabis (TSX:ACB)(NYSE:ACB) stock has been decimated over the last year. Shares are trading 84% below 52-week highs and investors are patiently waiting for a turnaround.

But Aurora Cannabis is grappling with several issues. Its high debt balance of $796 million is a major concern. Comparatively, the company has a cash balance of $192 million and operating cash flows of -$218 million. This indicates Aurora Cannabis can run out of cash if it does not improve profit margins at a fast pace.

Another issue is the competition from illegal sales that still accounts for 40% of total cannabis sales in Canada. The slower than expected rollout of retail stores in major Canadian provinces has also led to high inventory levels, further pressurizing sales and the bottom line.

Last week, Aurora Cannabis announced the exit of its founder and CEO. It also announced a 15% cut in the workforce and the company also released preliminary quarterly results that were below consensus estimates, resulting in a 16% drop in stock price on Friday.

And it’s not just Aurora Cannabis: several other pot stocks have lost billions of dollars in market value in the last 12-months. However, the pot industry is still in a nascent stage, which means it will grow at a rapid pace over the years.

So how do investors take advantage of this growth? Well, there is one pot company that is relatively safe and even provides a dividend. Yes, you heard that right.

Innovative Industrial Properties Inc.

Innovative Industrial Properties Inc. (NYSE:IIPR) is not your traditional pot company. It does not have greenhouse facilities to manufacture products. IIPR focuses on the acquisition, ownership and management of industrial properties, which it leases to licensed cannabis producers.

IIPR acquires properties through sale-leaseback transactions and third-party purchases. This business model has served the company well. In the September quarter, IIPR more than tripled rental sales year over year, while adjusted funds from operations more than quadrupled.

The company owns 49 properties in 15 states south of the border. Some of its clients are large cannabis companies such as Cresco Labs and Trulieve Cannabis.

IIPR has increased sales from USD $0.32 million in 2016 to USD $14.8 million in 2018. Analysts expect sales to reach USD $166 million by the end of 2021.

IIPR shares went public in December 2016 and closed trading at USD $18.45 on December 2 of that year. The stock has gained 400% in just over three years. While most pot stocks have lost over 60% in market value in the last year, IIPR is trading 34% below its 52-week high.

Another encouraging aspect of the stock is the company’s forward dividend yield of 4.3%. Although IIPR has a debt balance of $134 million, with cash reserves of $100 million and operating cash flows of $31.2 million, it can easily service debt obligations.

IIPR has a capital intensive business model, which means that it will have to issue additional capital to sustain its aggressive expansion goals.

However, the company is already profitable, with a forward price-to-earnings multiple of 20.5 — an absolute bargain given that earnings could rise 134.7% in 2019 and 156.2% in 2020.

Analysts covering IIPR have an average 12-month price target of USD $140.5, which is 52% above the current trading price.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Aditya Raghunath has no position in any of the stocks mentioned.

More on Cannabis Stocks

edit Jars of marijuana
Cannabis Stocks

Is Tilray Stock a Buy in the New Bullish Market?

Canadian cannabis producer Tilray has underperformed the broader markets in the last five years due to its weak fundamentals.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 10-Foot Pole

Down 99% from all-time highs, Aurora Cannabis stock remains a high-risk bet due to its weak fundamentals and risky liquidity…

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Has Been on a Roller Coaster: Is it a Good Buy?

In their relatively small lifetime, most cannabis stocks in Canada have seen both extreme highs and massive slumps. But their…

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Canopy Growth Stock Surged 100% Last Month: Is It a Good Buy Now?

Canopy Growth soared more than 160% last month. Can the TSX cannabis stock continue to mover higher in 2024?

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »